Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Home :  Regulatory Policy :  RegWatch : 
RegWatch:     

News & Analysis | REG•WATCH Blog | Press Room

 R    E    G    •    W    A    T    C    H 


Monday, June 04, 2007

FDA to Establish Panel on Risk Communication

FDA has announced the creation of an advisory panel which will aid agency officials in communicating food and drug safety risks to the public. Last year, the Institute of Medicine recommended Congress pass legislation creating such a panel.

FDA should be applauded being proactive on the recommendation. During recent food and drug safety crises, FDA has seemed unwilling or unable to allay public fears with immediate communications and relevant information. Establishing this panel has the benefit of being both good politics and good policy.

But policy and politics don't always get along so well. Members of this panel will need to be unbiased and apolitical in their assessments of food and drug safety and the need for public outreach. Even so, because political officials will likely be doing most of the actual communicating, the potential for politically-motivated cover-ups remains.

The Institute of Medicine report states:

The expertise needed on the advisory committee may include consumer and patient perspectives…risk communication, health literacy, social marketing expertise, public relations expertise, social sciences expertise with an emphasis on qualitative research and survey science, journalism, and ethics.
Conspicuously absent from that list is industry. If FDA truly intends to create this panel in the spirit of the report, it will keep industry allies off. (FDA will be accepting public nominations for the panel.)

Even if FDA improves its regulatory actions and post-market surveillance, drug and food safety problems are inevitable. America needs a trusted voice in these situations. One of the roles of government should be to provide that voice.



Posted by Matt Madia



Entries by Theme

All Themes

Enforcement

About This Blog

Rollbacks

Safety

Industry Influence

Cost-Benefit Analysis

In Congress

Publications

Consumer Issues

Environment

Public Health

In the Courts

Oversight

In the White House

Most Recent Entries for RegWatch

Occupational Risk Rule Clears White House

With Concessions to Industry, Right Whale Rule May Be Moving

In Rare Move, White House Rubber Stamped Abortion Proposal

Controversial Rule on Abortion Moving Forward

Bush Administration Backs Off SCHIP Restrictions

Bush Signs Consumer Product Safety Bill

Bush Administration Cuts Habitat for Spotted Owl

Bush Trying Last-Minute Changes to Endangered Species Act

For EPA Staff Trying to Protect the Planet, "Disappointment is Profound"

Consumer Product Bill Delivers Win for Consumers

Archived Entries for Public Health

August

July

June

May

April

March

February

January

December, 2007

November, 2007

October, 2007

September, 2007

August, 2007

July, 2007

June, 2007

May, 2007

April, 2007

March, 2007

February, 2007

January, 2007

December, 2006

November, 2006

October, 2006

September, 2006

August, 2006

June, 2006

May, 2006

April, 2006

March, 2006

January, 2006

December, 2005

November, 2005

October, 2005

September, 2005

August, 2005

July, 2005

June, 2005

May, 2005

April, 2005

March, 2005

February, 2005

January, 2005

December, 2004

November, 2004

October, 2004